Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort

Lev Prasov, Bin Guan, Ehsan Ullah, Steven M. Archer, Bernadete Ayres, Cagri G. Besirli, Laurel Wiinikka-Buesser, Grant M. Comer, Monte A. Del Monte, Victor M. Elner, Sarah J. Garnai, Laryssa A. Huryn, Kayla Johnson, Shivani Kamat, Philip Lieu, Shahzad I. Mian, Christine A. Rygiel, Jasmine Y. Serpen, Hemant Pawar, Brian P. Brooks, Sayoko E. Moroi, Julia E. Richards, Robert B. HufnagelScientific 2020 · DOI

TL;DR

This study investigates the genetic underpinnings of nanophthalmos and high hyperopia in a large US cohort, identifying novel variants in known genes like TMEM98, MFRP, and PRSS56. The findings highlight that while these genes play a role, a significant portion of these conditions remain genetically unexplained, suggesting the involvement of undiscovered genes or complex genetic interactions.

What Problem Does This Paper Address?

Nanophthalmos, characterized by a small but structurally normal eye leading to severe farsightedness (high hyperopia), is a rare but visually debilitating condition. While six genes (MFRP, PRSS56, MYRF, TMEM98, CRB1, VMD2/BEST1) have been linked to nanophthalmos and high hyperopia, their precise contribution to the spectrum of these conditions, especially in a diverse population like the United States, is not fully understood. This paper aims to elucidate the prevalence of pathogenic variants in these known genes within a large cohort of US families affected by nanophthalmos and high hyperopia, and to explore potential genotype-phenotype correlations.

Methods

The researchers employed a combination of genetic analysis techniques. High-throughput panel sequencing and pooled exome sequencing were used to screen for variants in known nanophthalmos-associated genes. For specific families, linkage analysis was performed to narrow down chromosomal regions containing potential disease-causing genes. Sanger sequencing was used to confirm identified variants and for segregation analysis within families. Homology modeling was utilized to predict the structural impact of novel missense variants. Variants were classified using standardized American College of Medical Genetics (ACMG) criteria, and their pathogenicity was further assessed using in-silico prediction tools and population frequency data from gnomAD.

Datasets

The study utilized a cohort of 56 probands and their families from the United States, with 53 families passing quality control. These families were characterized by either nanophthalmos (axial length ≤ 21.0 mm) or high hyperopia (spherical equivalent ≥ +5.50 D). No new benchmark datasets were introduced; the focus was on analyzing an existing cohort with known genetic conditions.

Key Insights and Ideas

  • Significant Genetic Heterogeneity: Even within a defined set of known genes, the genetic causes of nanophthalmos and high hyperopia are diverse, with multiple genes contributing and a substantial number of cases remaining unexplained.
  • Novel Variants Identified: The study successfully identified novel, potentially disease-causing variants in TMEM98, MFRP, and PRSS56, expanding the known mutational spectrum for these genes.
  • TMEM98 Variant's Impact: A novel TMEM98 variant, p.(Arg201Pro), was found to segregate with nanophthalmos in a family, highlighting its role in the condition and suggesting that proline substitutions in helix 5 of the TMEM98 protein may be particularly disruptive.
  • MFRP and PRSS56 Phenotypic Tendencies: While not absolute, there appear to be some genotype-phenotype correlations. MFRP families were more prone to retinal degeneration, while PRSS56 families were more likely to exhibit choroidal folds.
  • Large Unexplained Proportion: A striking finding is that a majority of cases (over 80%) in this cohort could not be explained by variants in the currently known nanophthalmos genes, underscoring the need for further gene discovery.

Key Results

  • Plausible genetic diagnoses were identified in 10 out of 53 families (18.8%).
  • Specifically, 5 families (9.4%) had variants in MFRP, 4 families (7.5%) in PRSS56, and 1 family (1.9%) in TMEM98.
  • An additional 4 families (7.5%) had single allelic hits in MFRP or PRSS56, suggesting potential roles for gene dosage or undiscovered regulatory variants.
  • A novel TMEM98 variant (NM_015544.3, c.602G>C, p.(Arg201Pro)) was identified and segregated with the disease in 4 affected family members.
  • Multiple novel missense and frameshift variants in MFRP and PRSS56 were also identified.
  • Familial cases had a higher rate of solved diagnoses (43%) compared to sporadic cases (10%).
  • Nanophthalmos cases were more likely to be solved (22%) than high hyperopia cases (0%).

Limitations and Future Work

  • Unexplained Cases: The most significant limitation is that over 80% of the cohort's cases remain genetically unexplained by known nanophthalmos genes. This suggests the existence of undiscovered genes, complex genetic interactions, or regulatory/deep intronic variants.
  • Strict Criteria: The authors note that using strict ACMG criteria reduces the "solved" rate, implying that some "plausibly solved" cases might be reclassified with further research.
  • Genotype-Phenotype Correlations: While some trends were observed (e.g., MFRP and retinal degeneration, PRSS56 and choroidal folds), these were not absolute, indicating significant phenotypic variability even within families with the same genetic diagnosis.
  • Future Directions: The study strongly advocates for continued gene discovery efforts to identify novel genes involved in nanophthalmos and high hyperopia. Further investigation into the functional impact of identified variants, particularly those with single allelic hits, is warranted. Exploring gene-environment interactions and regulatory variants could also shed light on the remaining unexplained cases.

Summary updated

Abstract

Nanophthalmos is a rare condition defined by a small, structurally normal eye with resultant high hyperopia. While six genes have been implicated in this hereditary condition (MFRP, PRSS56, MYRF, TMEM98, CRB1,VMD2/BEST1), the relative contribution of these to nanophthalmos or to less severe high hyperopia (≥ + 5.50 spherical equivalent) has not been fully elucidated. We collected probands and families (n = 56) with high hyperopia or nanophthalmos (≤ 21.0 mm axial length). Of 53 families that passed quality control, plausible genetic diagnoses were identified in 10/53 (18.8%) by high-throughput panel or pooled exome sequencing. These include 1 TMEM98 family (1.9%), 5 MFRP families (9.4%), and 4 PRSS56 families (7.5%), with 4 additional families having single allelic hits in MFRP or PRSS56 (7.5%). A novel deleterious TMEM98 variant (NM_015544.3, c.602G>C, p.(Arg201Pro)) segregated with disease in 4 affected members of a family. Multiple novel missense and frameshift variants in MFRP and PRSS56 were identified. PRSS56 families were more likely to have choroidal folds than other solved families, while MFRP families were more likely to have retinal degeneration. Together, this study defines the prevalence of nanophthalmos gene variants in high hyperopia and nanophthalmos and indicates that a large fraction of cases remain outside of single gene coding sequences.
BibTeX
@inproceedings{prasov2020novel,
  author = {Lev Prasov and Bin Guan and Ehsan Ullah and Steven M. Archer and Bernadete Ayres and Cagri G. Besirli and Laurel Wiinikka-Buesser and Grant M. Comer and Monte A. Del Monte and Victor M. Elner and Sarah J. Garnai and Laryssa A. Huryn and Kayla Johnson and Shivani Kamat and Philip Lieu and Shahzad I. Mian and Christine A. Rygiel and Jasmine Y. Serpen and Hemant Pawar and Brian P. Brooks and Sayoko E. Moroi and Julia E. Richards and Robert B. Hufnagel},
  title = {{Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort}},
  booktitle = {Scientific},
  year = {2020},
  doi = {10.1038/s41598-020-76725-8},
}
Figure